ContractClinical Trial Agreement • June 26th, 2022
Contract Type FiledJune 26th, 2022CLINICAL TRIAL AGREEMENT SMLOUVA O KLINICKÉM HODNOCENÍ THIS CLINICAL TRIAL AGREEMENT(together with Attachment A, the “Agreement”) among TATO SMLOUVA O KLINICKÉMHODNOCENÍ (společně s přílohou A, dále jen„smlouva“) mezi AGIOS PHARMACEUTICALS, INC., a UnitedStates Delaware corporation with an office at 88 Sidney Street, Cambridge, MA 02139, VAT number: 26-0662915 (“Sponsor” or “Agios”) represented by Labcorp Drug Development Inc., Inc. located at 206 Carnegie Center, Princeton, New Jersey, 08540-6233, USA, VAT number: 22- 3265977 and its affiliates (“CRO” or “Labcorp”), for the purpose of signing the Agreement on behalf of the Sponsor; and represented by its Legal Representative Agios Netherlands B.V., Regus WTC, Zuidplein 36, 1077 XV Amsterdam, Noord- Holland, Netherlands, in the capacity of Proxy pursuant to a certain power of attorney granted on XXX. AGIOS PHARMACEUTICALS, INC.,společností registrovanou ve státě Delaware ve Spojených státech amerických se sídlem na adrese 88 Sidn